Cargando…
TRIM8: a double-edged sword in glioblastoma with the power to heal or hurt
Glioblastoma multiforme (GBM) is an aggressive primary brain tumor and one of the most lethal central nervous system tumors in adults. Despite significant breakthroughs in standard treatment, only about 5% of patients survive 5 years or longer. Therefore, much effort has been put into the search for...
Autores principales: | Hosseinalizadeh, Hamed, Mohamadzadeh, Omid, Kahrizi, Mohammad Saeed, Razaghi Bahabadi, Zahra, Klionsky, Daniel J., Mirzei, Hamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869596/ https://www.ncbi.nlm.nih.gov/pubmed/36690946 http://dx.doi.org/10.1186/s11658-023-00418-z |
Ejemplares similares
-
Paper-based biosensors as point-of-care diagnostic devices for the detection of cancers: a review of innovative techniques and clinical applications
por: Mahmoodpour, Mehrdad, et al.
Publicado: (2023) -
Roles of Non-coding RNAs and Angiogenesis in Glioblastoma
por: Balandeh, Ebrahim, et al.
Publicado: (2021) -
Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword
por: Wu, Mengwan, et al.
Publicado: (2022) -
Double-edged sword.
Publicado: (1994) -
Regulating the regulatory T cells as cell therapies in autoimmunity and cancer
por: Hosseinalizadeh, Hamed, et al.
Publicado: (2023)